Intensive therapy with autologous stem cell transplantation as first-line therapy in poor-risk Hodgkin's disease and analysis of predictive factors of outcome. [electronic resource]
Producer: 19990921Description: 305-13 p. digitalISSN:- 1042-8194
- Adolescent
- Adult
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Bleomycin -- therapeutic use
- Disease-Free Survival
- Doxorubicin -- therapeutic use
- Etoposide -- therapeutic use
- Female
- Hematopoietic Stem Cell Transplantation
- Hodgkin Disease -- therapy
- Humans
- Ifosfamide -- therapeutic use
- Male
- Mechlorethamine -- therapeutic use
- Middle Aged
- Mitoguazone -- therapeutic use
- Outcome Assessment, Health Care
- Prednisolone -- therapeutic use
- Prednisone -- therapeutic use
- Procarbazine -- therapeutic use
- Prognosis
- Prospective Studies
- Vinblastine -- analogs & derivatives
- Vincristine -- therapeutic use
No physical items for this record
Publication Type: Clinical Trial; Journal Article
There are no comments on this title.
Log in to your account to post a comment.